1. Home
  2. PAHC vs FNA Comparison

PAHC vs FNA Comparison

Compare PAHC & FNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • FNA
  • Stock Information
  • Founded
  • PAHC 1946
  • FNA 2010
  • Country
  • PAHC United States
  • FNA United States
  • Employees
  • PAHC N/A
  • FNA N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PAHC Health Care
  • FNA Health Care
  • Exchange
  • PAHC Nasdaq
  • FNA Nasdaq
  • Market Cap
  • PAHC 682.5M
  • FNA 590.6M
  • IPO Year
  • PAHC 2014
  • FNA 2021
  • Fundamental
  • Price
  • PAHC $24.46
  • FNA $10.00
  • Analyst Decision
  • PAHC Sell
  • FNA Strong Buy
  • Analyst Count
  • PAHC 3
  • FNA 5
  • Target Price
  • PAHC $19.00
  • FNA $15.60
  • AVG Volume (30 Days)
  • PAHC 174.8K
  • FNA 817.5K
  • Earning Date
  • PAHC 11-06-2024
  • FNA 11-12-2024
  • Dividend Yield
  • PAHC 1.96%
  • FNA N/A
  • EPS Growth
  • PAHC N/A
  • FNA N/A
  • EPS
  • PAHC 0.43
  • FNA N/A
  • Revenue
  • PAHC $1,046,762,000.00
  • FNA $244,995,000.00
  • Revenue This Year
  • PAHC $21.75
  • FNA $17.47
  • Revenue Next Year
  • PAHC $12.67
  • FNA $16.35
  • P/E Ratio
  • PAHC $56.92
  • FNA N/A
  • Revenue Growth
  • PAHC 7.17
  • FNA 18.16
  • 52 Week Low
  • PAHC $9.49
  • FNA $4.65
  • 52 Week High
  • PAHC $25.98
  • FNA $14.79
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 56.80
  • FNA 76.69
  • Support Level
  • PAHC $24.23
  • FNA $5.07
  • Resistance Level
  • PAHC $25.98
  • FNA $10.68
  • Average True Range (ATR)
  • PAHC 0.90
  • FNA 0.66
  • MACD
  • PAHC 0.08
  • FNA 0.51
  • Stochastic Oscillator
  • PAHC 60.21
  • FNA 88.80

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About FNA Paragon 28 Inc.

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: